Pharma Giants Label GLP-1 Agonists as Longevity Breakthroughs at ARDD Conference
September 15, 2025
At the ARDD conference in Copenhagen, leading pharmaceutical companies such as Eli Lilly and Novo Nordisk openly described GLP-1 receptor agonists as longevity drugs, signaling a significant shift in how the industry perceives and approaches aging.
Summary based on 1 source
Get a daily email with more Longevity stories
Source
Longevity.Technology - Latest News, Opinions, Analysis and Research • Sep 15, 2025
GLP-1s claim the longevity stage at ARDD